Abstract:Modification of histones is one of the important mechanisms of epigenetics, in which genetic control is determined by factors other than an individual's DNA sequence. Sirtuin family proteins, which are class III histone deacetylases, were originally identified as gene silencers that affect the mating type of yeast, leading to the name "silent mating-type information regulation 2" (SIR2). They are characterized by their requirement of nicotinamide adenine dinucleotide for their enzyme activity, unlike other classes of histone deacetylases. Sirtuins have been traditionally linked to longevity and the beneficial effects of calorie restriction and DNA damage repair. Recently, sirtuins have been shown to be involved in a wide range of physiological and pathological processes, including aging, energy responses to low calorie availability, and stress resistance, as well as apoptosis and inflammation. Sirtuins can also regulate mitochondrial biogenesis and circadian clocks. Seven sirtuin family proteins (Sirt1-7) have been identified as mammalian SIR2 orthologs, localized in different subcellular compartments, namely, the cytoplasm (Sirt1, 2), the mitochondria (Sirt3, 4, 5), and the nucleus (Sirt1, 2, 6, 7). Sirt1 is evolutionarily close to yeast SIR2 and has been the most intensively investigated in the cardiovascular system. Endogenous Sirt1 plays a pivotal role in mediating the cell death/survival process and has been implicated in the pathogenesis of cardiovascular disease. Downregulation of Sirt2 is protective against ischemic-reperfusion injury. Increased Sirt3 expression has been shown to correlate with longevity in humans. In addition, Sirt3 protects cardiomyocytes from aging and oxidative stress and suppresses cardiac hypertrophy. Sirt6 has also recently been demonstrated to attenuate cardiac hypertrophy, and Sirt7 is known to regulate apoptosis and stress responses in the heart. On the other hand, the roles of Sirt4 and Sirt5 in the heart remain largely uncharacterized.

SIRT6 in Senescence and Aging-Related Cardiovascular Diseases

SIRT6 in Aging, Metabolism, Inflammation and Cardiovascular Diseases

Sirtuin 6: A Potential Therapeutic Target for Cardiovascular Diseases.

The Role of Mammalian Sirtuin 6 in Cardiovascular Diseases and Diabetes Mellitus

SIRT6 Widely Regulates Aging, Immunity, and Cancer

SIRT6 serves as a polyhedron in glycolytic metabolism and ageing-related diseases

SIRT6 in DNA repair, metabolism and ageing

Emerging roles of SIRT6 on telomere maintenance, DNA repair, metabolism and mammalian aging

Cardioprotective Effects of SIRT6 in a Mouse Model of Transverse Aortic Constriction-Induced Heart Failure.

SIRT1 in metabolic syndrome: where to target matters.

Regulation of SIRT1 in aging: Roles in mitochondrial function and biogenesis

Abstract 186: Impaired Nucleocytoplasmic Shuttling and Activity of SIRT1 in Response to Ischemic Stress in the Senescent Heart

Sirtuins in Cardiovascular Health and Diseases

SIRT6 Protects Against Endothelial Dysfunction and Atherosclerosis in Mice

The Role of Increased Expression of Sirtuin 6 in the Prevention of Premature Aging Pathomechanisms

SIRT6 activates PPARα to improve doxorubicin-induced myocardial cell aging and damage

SIRT1 in vascular related diseases:its progress

The role of sirtuins in cardiac disease

Sirtuin 6 attenuates angiotensin II-induced vascular adventitial aging in rat aortae by suppressing the NF-κB pathway

The Role of Sirt6 in Obesity and Diabetes

Research Progress on Sirtuins Family Members and Cell Senescence.